Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
New report raises questions about data that helped heart drug gain FDA approval
Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.

American Indians have an especially high risk of stroke, leaving researchers with many questions

The study included data from nearly 17 million adults who received treatment from 2005 to 2011. Researchers compared the stroke rates of patients with atrial fibrillation and those without it.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

Shockwave’s IVL technology gains FDA approval for treating advanced coronary artery disease

Shockwave Medical announced Tuesday, Feb. 16, that intravascular lithotripsy (IVL) has gained FDA approval for the treatment of severely calcified coronary artery disease.

Statins still effective in older stroke patients, reducing the risk of cardiovascular events and death

The study's authors aimed to learn more about an area where clinical evidence was lacking: statin therapy for stroke patients 80 years old and older.

Direct oral anticoagulants safer than warfarin for AFib patients with bioprosthetic heart valves

The analysis, published in the American Journal of Cardiology, focused on both the safety and effectiveness of these two treatment options.

Drinking green tea or coffee can reduce all-cause mortality for stroke, heart attack survivors

Drinking coffee also benefits patients who have not experienced a stroke or heart attack, though the impact is not as significant.

USPSTF recommends against screening healthy adults for carotid artery stenosis

"Screening for CAS in adults without symptoms does more harm than good, and we continue to recommend against it," one USPSTF representative said.

American Heart Association explores close ties between mental, cardiovascular health

Depression, chronic stress, anxiety and anger are all associated with a heightened risk of heart rhythm irregularities, stroke and other serious cardiovascular conditions.

What new research tells us about stroke mortality among men and women

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis.

Vascular & Endovascular

New guidelines help interventional cardiologists manage chronic venous disease

Private equity firm jumps into vascular health with new investment

New report raises questions about data that helped heart drug gain FDA approval

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

Angiographic catheters recalled due to safety risk